Prednisolone, Sulfacetamide

Vasocidin Ophthalmic Solution

2.5 MG / ML + 100 MG / ML LiquidCanadaCancelledAuthorised 31 Dec 1992

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

VasocidinUnited States · 0.23% PHOSPHATE; 10% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · solution/drops · NovartisSame brand
VasocidinUnited States · 0.5%; 10% · ointment · NovartisSame brand
Sulfacetamide Sodium and Prednisolone Sodium PhosphateUnited States · 0.23% PHOSPHATE; 10% · solution/drops · GenusSame form
Blephamide Eye DropsSaudi Arabia · Allergan Pharmaceuticals LTDSame substance
Cetapred Opth.Oint.Saudi Arabia · Alcon CouvreurSame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Prednisolone, Sulfacetamide

Vasocidin Ophthalmic Solution

2.5 MG / ML + 100 MG / ML LiquidCanadaCancelledAuthorised 31 Dec 1992

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Isoptocetapred Eye DropsSaudi Arabia · Alcon Couvreur

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Prednisolone, Sulfacetamide
Strength: 2.5 MG / ML + 100 MG / ML
Dosage form: Liquid
Route: Ophthalmic
Register: Canada (Health Canada)
Status: Cancelled
Status in the register: Cancelled Post Market
Authorised: 31 Dec 1992
Registration: DIN 00843741
Marketing authorisation holder: Iolab Pharmaceuticals
ATC code: S01CA02
Group: Sensory organs
Supply: PRESCRIPTION

Prednisolone/SulfacetamidePrednisolone + Sulfacetamide · 0.5 % / W/V + 10 % / W/V · SuspensionCanada

BlephamidePrednisolone + Sulfacetamide · 0.2 % + 10 % · DropsCanadaCancelled

Blephamide S.O.P.Prednisolone + Sulfacetamide · 0.2 % + 10 % · OintmentCanadaCancelled

Metimyd Oph SusPrednisolone + Sulfacetamide · 5 MG / ML + 100 MG / ML · SuspensionCanadaCancelled

Vasocidin Ophthalmic SolutionPrednisolone + Sulfacetamide · 2.5 MG / ML + 100 MG / ML · SolutionCanadaCancelled